Tailoring Upper Limb Exercise Advice for People With Parkinson Disease
Trial
N/A
Unknown
June 24, 2024
Investigating Muscle Training's Respiratory Outcomes and Voice Enhancement in Parkinson's Disease
Trial
N/A
Not yet recruiting
June 24, 2024
Highly Challenging Balance Program to Reduce Fall Rate in PD
Trial
N/A
Completed
June 20, 2024
Enhancing Referral Decision-making for Advanced Treatment in Parkinson's Disease Through Objective Measurements and Patient Reported Outcomes.
Trial
N/A
Not yet recruiting
June 20, 2024
The Effect of Psyllium and Wheat Bran on Body Weight in People With Parkinson's Disease and Constipation Symptoms
Trial
N/A
Completed
June 19, 2024
Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components
Trial
Phase 2
Terminated
June 16, 2024
A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia
Trial
Phase 2
Completed
June 16, 2024
Moving Mindfully for Freezing in Parkinsons
Trial
N/A
Completed
June 13, 2024
Determination of Risk Factors of Shoulder Pathologies in Parkinson Disease
Trial
N/A
Unknown
June 12, 2024
Non-invasive Detection of Volatile Metabolites in Parkinson's Disease
Trial
N/A
Unknown
June 12, 2024
AV133 Longitudinal Imaging Study in Patients With Early and Prdromal Parkinson's Disease
Trial
N/A
Recruiting
June 12, 2024
Effects of Biofeedback Footwear in Parkinson's Disease: Assessment of Functional Motor Abilities and Locomotion
Trial
N/A
Unknown
June 12, 2024
Prevalence of Visual Dysfunction in Neurological Disorders
Trial
N/A
Completed
June 11, 2024
Bioequivalence Study of Pimavanserin 34 mg Capsule
Trial
Phase 1
Completed
June 9, 2024
Evaluation of a Decision Aid for Deep Brain Stimulation Surgery for Parkinson's Disease
Trial
N/A
Unknown
June 5, 2024
Oral Therapeutic Education in Stimulated Parkinsonian Patients
Trial
N/A
Terminated
June 5, 2024
Golf, Physical Rehabilitation, and Movement Disorders
Trial
N/A
Completed
June 5, 2024
Phase II Clinical Study of TR-012001 in Japanese Patients With Parkinson's Disease
Trial
Phase 2
Completed
June 5, 2024